Gilead Sciences (GILD) Cash from Investing Activities (2016 - 2025)
Gilead Sciences' Cash from Investing Activities history spans 17 years, with the latest figure at -$1.8 billion for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 715.56% year-over-year to -$1.8 billion; the TTM value through Dec 2025 reached -$4.8 billion, down 38.97%, while the annual FY2025 figure was -$4.8 billion, 38.97% down from the prior year.
- Cash from Investing Activities reached -$1.8 billion in Q4 2025 per GILD's latest filing, down from -$427.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$225.0 million in Q4 2024 to a low of -$2.2 billion in Q1 2024.
- Average Cash from Investing Activities over 5 years is -$805.2 million, with a median of -$530.0 million recorded in 2021.
- Peak YoY movement for Cash from Investing Activities: surged 96.9% in 2021, then tumbled 715.56% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$278.0 million in 2021, then crashed by 34.89% to -$375.0 million in 2022, then crashed by 93.87% to -$727.0 million in 2023, then surged by 69.05% to -$225.0 million in 2024, then crashed by 715.56% to -$1.8 billion in 2025.
- Per Business Quant, the three most recent readings for GILD's Cash from Investing Activities are -$1.8 billion (Q4 2025), -$427.0 million (Q3 2025), and -$2.1 billion (Q2 2025).